|1.||Zhang, Baolin: 4 articles (10/2015 - 07/2005)|
|2.||Yoo, Jiyun: 4 articles (10/2014 - 01/2010)|
|3.||Cho, Hee Jun: 4 articles (10/2014 - 01/2010)|
|4.||Hong, Soon-Chan: 4 articles (10/2014 - 09/2010)|
|5.||Baek, Kyoung Eun: 4 articles (10/2014 - 01/2010)|
|6.||Theodorescu, Dan: 4 articles (05/2010 - 08/2005)|
|7.||Zhang, Yaqin: 3 articles (10/2015 - 07/2005)|
|8.||Ryu, Ki-Jun: 3 articles (10/2014 - 11/2013)|
|9.||Kim, In-Kyu: 3 articles (10/2014 - 11/2013)|
|10.||Park, Seung-Ho: 3 articles (10/2014 - 11/2013)|
01/15/2013 - "Bcl3 knockdown resulted in a 61% decrease in tumor cell motility and a concomitant increase in the cell migration inhibitors Nme1, Nme2, and Nme3, the GDP dissociation inhibitor Arhgdib, and the metalloprotease inhibitors Timp1 and Timp2. "
04/20/2012 - "We further demonstrated that RhoGDI SUMOylation at Lys-138 was crucial for inhibiting actin polymerization and cytoskeleton formation as well as cancer cell motility. "
01/01/2012 - "Although the Rho GDP dissociation inhibitor β (ARHGDIB) gene has been found to be ubiquitously expressed in normal tissues and involved in cancer development, the presence of splice variants of ARHGDIB has not yet been investigated. "
11/01/2010 - "Rho GDI is frequently overexpressed in many human cancers. "
05/01/2010 - "RhoGDI signaling provides targets for cancer therapy."
|2.||Breast Neoplasms (Breast Cancer)
10/20/2015 - "Further, we assessed the expression level of RhoGDI protein in breast tumor specimens (n = 165) by immunohistochemistry. "
12/05/2014 - "Particularly, we confirmed the overexpression of the Rho-GDP dissociation inhibitor 2 (RhoGDI-2) in distinct breast cancer subtypes, as well as in metastatic cell lines derived from lung, prostate, and breast cancer. "
02/01/2010 - "Rho-GDIalpha is possibly a useful biomarker to predict the response of breast cancer patients to CMF treatment."
02/01/2010 - "There is evidence, that Rho-GDIalpha may modulate drug resistance of breast cancer cells. "
02/01/2010 - "Rho GDP dissociation inhibitor alpha expression correlates with the outcome of CMF treatment in invasive ductal breast cancer."
06/05/2011 - "An interaction between the Tobacco mosaic virus (TMV) 126kDa replication protein and a host-encoded Rab GDP dissociation inhibitor (GDI2) was identified and investigated for its role in infection. "
01/01/2014 - "typhimurium were gluconeogenesis and Rho GDI/RhoA signaling, and our results suggest that keratins and the intermediate filaments could play an important role in the damage of the mucosa and in the success of infection. "
11/01/2009 - "CARD9 associated with the GDP-dissociation inhibitor LyGDI in phagosomes after bacterial and fungal infection and binding of CARD9 suppressed LyGDI-mediated inhibition of the GTPase Rac1, thereby leading to ROS production and bacterial killing in macrophages. "
03/01/2008 - "Western blot further confirmed the inhibition of Rho protein GDP dissociation inhibitor expression and the induction of polyubiquitin during IBDV infection. "
05/01/2010 - "Studies about changes in protein intensities were complemented by an analysis of protein phosphorylation that revealed infection-associated changes in the phosphorylation of myosin binding protein C, atrial and ventricular isoforms of myosin regulatory light chain 2, desmin, and Rab GDP dissociation inhibitor beta-2."
|4.||Hepatocellular Carcinoma (Hepatoma)
01/31/2014 - "In this study, increased expression of RhoGDI was detected in hepatocellular carcinoma (HCC) cell lines and tissues with highly metastatic potential. "
11/01/2014 - "Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma."
01/01/2013 - "Loss of RhoGDI is a novel independent prognostic factor in hepatocellular carcinoma."
11/01/2014 - "Rho GDP dissociation inhibitor (GDI) beta, (RhoGDI2), has been identified as a proto-oncogene that is upregulated in human cancers, but the role of RhoGDI2 in hepatocellular carcinoma (HCC) remains unclear. "
01/31/2014 - "Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma."
|5.||Colorectal Neoplasms (Colorectal Cancer)
09/01/2008 - "In this study, we used comparative proteomic analysis to show that RhoGDI is markedly up-regulated in metastatic colorectal cancer (CRC). "
04/01/2012 - "Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma."
09/01/2008 - "Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer."
|1.||GTP Phosphohydrolases (GTPases)
|2.||Proteins (Proteins, Gene)
|4.||X-Linked Inhibitor of Apoptosis Protein
|6.||Monomeric GTP-Binding Proteins
|7.||GTP-Binding Proteins (G-Protein)
|9.||Troponin T (T, Troponin)
|10.||Protein Isoforms (Isoforms)
|2.||Drug Therapy (Chemotherapy)
|4.||Heterologous Transplantation (Xenotransplantation)